Venture Capital
Andrea Alms Video: Money In Motion 50 - The Biomaterials Market
March 2023 - Venture Capital
TRANSCRIPT: Hello, my name is Andrea Alms. I am technology investor and financial manager and this is your money in motion. I was asked about biomaterials. Biomaterials are compatible to your body and do not trigger any inflammatory reaction. The orthopedic application segment captured maximum revenue share in the global market, rising adoption of metallic biomaterials owing to their high load bearing capacity is one of the main driving factors.
For instance, in November 2019, FDA approved ZF ZF for spine Interbody device introduced by diffusion that is based on diffuse a different biomaterial that is made up of titanium and poly ether ether ketone according to precedence research. The global biomaterials market is valued at $110 billion in 2020 and expected to hit about $390 billion in 2027, growing at a noteworthy compound average growth rate of 15% from 2020 to 2027.
VMI report. The market size is about $109.39 billion in 2019 and is expected to reach $328.37 billion by 2027, growing at a compound average growth rate of 15.89% from 2019 to 2027, Grandview research reports. The market size was estimated $135 billion in 2021, and the compound average growth rate of 50% from 2021 to 2030. Averaging best guess estimates about $118.3 billion.
Is the market size growing at 15.5%. Compound average growth rate, a multi-billion dollar market, double digit growth. Definitely. Let's keep an eye on this one. Thank you. This is your money, your money in motion.